• Publication frequency quarterly
  • approx. 70 pages
  • ISSN 2751-3971
  • eISSN 2751-398X
  • Language: English

EHPL 2/2023 Out Now

The second issue of the European Health & Pharmaceutical Law Review in 2023 is now available. The issue features the following articles and reports:

View all articles from the latest issue of EHPL here.

Become an author for EHPL and view our Call for Papers.

Find the online Archive of EHPL – European Health & Pharmaceutical Law Review right here


Do you want to make your contribution freely available to the public? All Open Access Information below.


About EHPL

The EHPL – European Health & Pharmaceutical Law  identifies and analyses important legal and regulatory developments on the national, EU and international level. It is primarily concerned with pharmaceutical law, medicines law and issues related to the work of the European Medicines Agency (EMA).

Furthermore, it provides an overview of and critically examines judgments and directives that shape the interpretation and application of EU pharmaceutical law and policy, including those by the European Medicines Agency (EMA), European Courts, international courts and tribunals such as the WTO’s Dispute Settlement Body, and higher national courts.

EHPL’s Aims & Scope

In order to establish itself as a forum for dialogue between different stakeholders in pharmaceutical regulation and governance, EHPL invites contributions from academics, practitioners, regulators and civil society representatives.

Topics covered by EHPL include:

  • Pharmaceutical law and policy in all jurisdictions (regional, national, international);
  • Medicines law
  • Commission decisions (EMA opinions) and regulatory guidelines;
  • National, EU, and international jurisprudence;
  • Medical devices;
  • Borderline cases: pharmaceuticals/food/cosmetics/chemicals
  • Patents /trademarks;
  • Health technology assessment and pricing/reimbursement;
  • Digital health/big data;

All contributions will be subject to double blind peer-review before acceptance for publication and are required to conform to the author guidelines.

EHPL's Target Audience

The quarterly journal addresses everyone who is concerned with pharmaceutical law and policy issues such as academics (in the field of medicines law, regulatory science, and other relevant research fields), legal practitioners in national and international law firms, regulators such government officials working in EU  and national public administration, judges and legal experts in domestic, European and international courts, consultancies, business people in the EU and beyond as well as stakeholder organisations representing professionals, patients, and civil society.

EHPL's Structure

Each issue of EHPL will be a balanced mixture of original research articles, first-hand country or thematic policy reports, timely case annotations on important ECJ/GC rulings and other international/national court judgments, book reviews as well as other information material and updates, including opinions, case summaries or event reports.


Managing Editor

Jakob Wested, University of Copenhagen

Editorial Board

Ulrich M. Gassner, University of Augsburg
Richard S. Goldberg, Durham University
Leigh Hancher, University of Tilburg / Allen & Overy
Isabelle Huys, KU Leuven
Tomasz Jablonski, European Medicines Agency
Els Janssens, Baker McKenzie
Trudo Lemmens, University of Toronto
Timo Minssen, University of Copenhagen
Vincenzo Salvatore, University of Insubria/BonelliErede
Florian Schmidt, European Commission
Santa Slokenberga, Uppsala University
George Peretz, Monckton Chambers
Claudia Seitz, University of Ghent
Eveline Van Keymeulen, Latham & Watkins LLP
Santa Slokenberga, Uppsala University
Anastasiya Kiseleva, Vrije Universiteit Brussel (VUB), CY Cergy Paris University (CYU)

Executive Editor

Jakob McKernan, Lexxion Publisher, Berlin

Open Access

Do you want to make your contribution freely available to the public?

This journal offers the option to publish open access (OA). Contributions published under the OA policy must still successfully pass peer review in accordance with the journal’s Author Guidelines (view them under the section ‘For authors’ on this website). The standard Open access fee for EPHL in 2023 is 952,00 € per contribution.

Other Options 

Gold Open Access

Gold OA makes the final version of an article freely and permanently accessible for everyone, immediately after publication. Copyright for the article is retained by the author(s). The Gold OA fee is €1190. All open access articles are subject to EHPL’s peer review process.

Green Open Access

After a 6-month embargo period, authors working at a university or a research institute, can avail of the Green OA option. Green OA allows the author to deposit their post-print submission in an institutional or disciplinary repository but not in commercial repositories such as SSRN or Academia.edu. The publisher retains the copyright. This option is free of charge.

If you have any questions please get in touch with our colleagues at info@lexxion.eu

Read some of the open access contributions for free here:

Legal Impact Assessment of Brexit: Clinical Trials Data Exchange and Data Protection by Lorelei Ana Garagancea, Walter Fürst (EPLR 1/2019)

Event Report – Big Data in the Pharmaceutical Sector by André S. Berne (EPLR 1/2019)

The Court as Pontius Pilate: Reflecting on Missed Opportunities in the PIP Decision by Marco Rizzi (EPLR 1/2017)

Advertising Rates and Cooperations

The advertising prices are valid from January 2023. Please provide the advert in a PDF-X-1a format + 3 mm bleed (without crop marks).

Print run: 500
Format: 207 mm width x 277 mm depth; adhesive binding
Placement Width in mm Depth in mm Prices in €
1/1 page
1/1 page truncated
1/2 page 157,50 107,00 700,00
Special placement
2nd cover page
3rd cover page
Colour surcharges per colour 300,00
Discount 3 Advertisements

6 Advertisements

3 %

5 %

Inserts/Supplements** 200,00 270,00 550,00
Banner ad on request

** Insert size 200 x 270 mm or smaller, or already folded.

Inserts/Supplements have to be delivered at least one week prior to publication date. Delivery address:

Schaltungsdienst Lange oHG
z.Hd. Fr. Schulz, Beilage EHPL _/2023 (Please state issue number.)
Zehrensdorfer Straße 11
12277 Berlin · Germany


Schedule 2023

Issue Date of Publication Advertising Deadline
EHPL 1/2023 31.03.2023 27.01.2023
EHPL 2/2023 30.06.2023 24.04.2023
EHPL 3/2023 29.09.2023 24.07.2023
EHPL 4/2023 20.12.2023 23.10.2023

(Changes excepted.)

For Authors

Submit article

Author Guidelines

Terms and Conditions

Publication Ethics and Malpractice Statement

Cases for Annotation

Events | Food, Chemical & Pharmaceutical Law

Stay informed

Related content

Media Partner

Subscribe to our newsletter to be regularly informed about our upcoming conferences, Lexxion Trainings, on-the-spot workshops and updates on Lexxion’s publications.

Don’t miss the news by signing up for our free newsletters. Sign up now!